1. Home
  2. UGRO vs PYPD Comparison

UGRO vs PYPD Comparison

Compare UGRO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$0.29

Market Cap

3.0M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.57

Market Cap

73.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
PYPD
Founded
2014
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
73.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
UGRO
PYPD
Price
$0.29
$4.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$3.00
$12.00
AVG Volume (30 Days)
13.7M
76.2K
Earning Date
02-17-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,985,138.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$28.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$2.30
52 Week High
$1.17
$4.63

Technical Indicators

Market Signals
Indicator
UGRO
PYPD
Relative Strength Index (RSI) 49.69 76.58
Support Level $0.27 $4.10
Resistance Level $0.31 $4.63
Average True Range (ATR) 0.06 0.18
MACD -0.00 0.05
Stochastic Oscillator 11.42 88.81

Price Performance

Historical Comparison
UGRO
PYPD

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: